Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells

Journal of Pediatric Surgery

Volumn 47, Issue 10, 2012, Pages 1797-1805

  Chen, Yun ^a,b   Tsai, Ya Hui ^a,b   Fang, Yu ^a   Tseng, Sheng Hong ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cisplatin; Drug resistance; miR 21; Neuroblastoma cells

Indexed keywords

ANTAGOMIR; CISPLATIN; MESSENGER RNA; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 84867492349     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2012.05.013     Document Type: Article

References (52)

1. G.M. Brodeur Neuroblastoma: biological insights into a clinical enigma Nat Rev Cancer 3 2003 203 216
2. K.K. Matthay Neuroblastoma: biology and therapy Oncology (Williston Park) 11 1997 1857 1866 [discussion 1869-1872, 1875]
3. A.D. Pearson, C.R. Pinkerton, and I.J. Lewis High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomized trial Lancet Oncol 9 2008 247 256
4. R.L. Stallings MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics Curr Pharm Des 15 2009 456 462
5. S. Aktas, Z. Altun, and Z. Erbayraktar Effect of cytotoxic agents and retinoic acid on Myc-N protein expression in neuroblastoma Appl Immunohistochem Mol Morphol 18 2009 86 89
6. G. Szakács, J.K. Paterson, and J.A. Ludwig Targeting multidrug resistance in cancer Nat Rev Drug Discov 5 2006 219 234
7. A. Roberti, D. La Sala, and C. Cinti Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective J Cell Physiol 207 2006 571 581
8. T. Fojo Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs Drug Resist Updat 10 2007 59 67
9. Y. Iwasa, M.A. Nowak, and F. Michor Evolution of resistance during clonal expansion Genetics 172 2006 2557 2566
10. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
11. N. Bushati, and S.M. Cohen microRNA functions Annu Rev Cell Dev Biol 23 2007 175 205
12. E. Barbarotto, T.D. Schmittgen, and G.A. Calin MicroRNAs and cancer: profile, profile, profile Int J Cancer 122 2008 969 977
13. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
14. L.P. Lim, N.C. Lau, and P. Garrett-Engele Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature 433 2005 769 773
15. J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
16. J.V. Tricoli, and J.W. Jacobson MicroRNA: potential for cancer detection, diagnosis, and prognosis Cancer Res 67 2007 4553 4555
17. T.E. Miller, K. Ghoshal, and B. Ramaswamy MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1 J Biol Chem 283 2008 29897 29903
18. O. Kovalchuk, J. Filkowski, and J. Meservy Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Mol Cancer Ther 7 2008 2152 2159
19. L. Xia, D. Zhang, and R. Du miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells Int J Cancer 123 2008 372 379
20. W. Zhu, X. Shan, and T. Wang miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines Int J Cancer 127 2010 2520 2529
21. R. Eitan, M. Kushnir, and G. Lithwick-Yanai Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients Gynecol Oncol 114 2009 253 259
22. Y. Fujita, K. Kojima, and N. Hamada Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells Biochem Biophys Res Commun 377 2008 114 119
23. M.M. Gottesman, and V. Ling The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research FEBS Lett 580 2006 998 1009
24. G.D. Leonard, T. Fojo, and S.E. Bates The role of ABC transporters in clinical practice Oncologist 8 2003 411 424
25. K.K. To, Z. Zhan, and T. Litman Regulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line Mol Cell Biol 28 2008 5147 5161
26. H. Zhu, H. Wu, and X. Liu Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem Pharmacol 76 2008 582 588
27. J.D. Walton, D.R. Kattan, and S.K. Thomas Characteristics of stem cells from human neuroblastoma cell lines and in tumors Neoplasia 6 2004 838 845
28. J.J. Molenaar, M.E. Ebus, and D. Geerts Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells Proc Natl Acad Sci U S A 106 2009 12968 12973
29. X. Wang A PCR-based platform for microRNA expression profiling studies RNA 15 2009 716 723
30. F. Meng, R. Henson, and H. Wehbe-Janek MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658
31. J. Tao, Q. Lu, and D. Wu microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells Oncol Rep 25 2011 1721 1729
32. K.A. Cole, E.F. Attiyeh, and Y.P. Mosse A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene Mol Cancer Res 6 2008 735 742
33. L. Fontana, M.E. Fiori, and S. Albini Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM PLoS One 3 2008 e2236
34. J.S. Wei, Y.K. Song, and S. Durinck The MYCN oncogene is a direct target of miR-34a Oncogene 27 2008 5204 5213
35. T. Boren, Y. Xiong, and A. Hakam MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy Gynecol Oncol 113 2009 249 255
36. R.D. Riley, D. Heney, and D.R. Jones A systematic review of molecular and biological tumor markers in neuroblastoma Clin Cancer Res 10 2004 4 12
37. H. Yang, W. Kong, and L. He MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433
38. C. Corcoran, A.M. Friel, and M.J. Duffy Intracellular and extracellular microRNAs in breast cancer Clin Chem 57 2011 18 32
39. C. Gong, Y. Yao, and Y. Wang Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer J Biol Chem 286 2011 19127 19137
40. H. Bai, R. Xu, and Z. Cao Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line FEBS Lett 585 2011 402 408
41. Y. Li, X. Zhu, and J. Gu Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis Hematology 15 2010 215 221
42. N. Valeri, P. Gasparini, and C. Braconi MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) Proc Natl Acad Sci U S A 107 2010 21098 21103
43. Y. Tomimaru, H. Eguchi, and H. Nagano MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells Br J Cancer 103 2010 1617 1626
44. Y. Li, W. Li, and Y. Yang MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme Brain Res 1286 2009 13 18
45. L. Shi, J. Chen, and J. Yang miR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity Brain Res 1352 2010 255 264
46. E. Giovannetti, N. Funel, and G.J. Peters MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity Cancer Res 70 2010 4528 4538
47. J. Buechner, J.R. Henriksen, and B.H. Haug Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells Differentiation 81 2011 25 34
48. J. Dong, Y.P. Zhao, and L. Zhou Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells Arch Med Res 42 2011 8 14
49. M. Folini, P. Gandellini, and N. Longoni miR-21: an oncomir on strike in prostate cancer Mol Cancer 9 2010 12
50. A. Misawa, R. Katayama, and S. Koike AP-1-dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells Oncol Res 19 2010 23 33
51. F. Talotta, A. Cimmino, and M.R. Matarazzo An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation Oncogene 28 2009 73 84
52. K. Wang, and P.F. Li Foxo3a regulates apoptosis by negatively targeting miR-21 J Biol Chem 285 2010 16958 16966